Skip to content

Study · Non-randomized trial · n = 53 · 2015

1 result

The use of kisspeptin as a novel physiological oocyte maturation trigger for patients undergoing IVF treatment

Christopoulos G

Imperial College London1 Jan 2015

DOI10.25560/25286 (opens in a new tab)PepBankPUB-96718290
Source linkSource pageAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In women having IVF after superovulation, egg maturation was observed in 96% (51/53) after a single subcutaneous kisspeptin‑54 injection.

    In plain wordsIn women having IVF, eggs matured in 96% of patients after one kisspeptin‑54 injection.

    Peptide
    Kisspeptin-54 (metastin)
    Outcome
    Not applicableEgg maturation rate
    Study

    n = 53

    Analysis
    Primary
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health
    Studied dose
    1.6, 3.2, 6.4 or 12.8 nmol/kg · subcutaneousAs given in this study (human).

    Measurements

    Egg maturation
    96%
    all doses

    Source sentences

    Summary
    Overall, egg maturation was observed in 96% (51/53) of patients.
    1 context sentence
    Summary · context
    Following superovulation with follicle stimulating hormone, and gonadotrophin releasing hormone antagonist administration to prevent premature ovulation, 53 women were administered a single subcutaneous injection of kisspeptin-54 (1.6nmol/kg, n=2; 3.2nmol/kg, n=3; 6.4nmol/kg, n=24; 12.8nmol/kg, n=24…

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 21:44 UTC

    Study results updated

  2. Version 1

    13 Oct 2026, 16:31 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.